6-mercaptopurine, an agonist of Nur77, reduces progression of pulmonary hypertension by enhancing BMP signalling

  • Kurakula K
  • Sun X
  • Happé C
  • et al.
ISSN: 0903-1936
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Pulmonary arterial hypertension (PAH) is a progressive fatal disease characterised by abnormal remodelling of pulmonary vessels, leading to increased vascular resistance and right ventricle failure. This abnormal vascular remodelling is associated with endothelial cell dysfunction, increased proliferation of smooth muscle cells, inflammation, and impaired bone morphogenetic protein (BMP) signalling. Orphan nuclear receptor Nur77 is a key regulator of proliferation and inflammation in vascular cells, but its role in the impaired BMP signaling and vascular remodelling in PAH is unknown.

Cite

CITATION STYLE

APA

Kurakula, K., Sun, X.-Q., Happé, C., da Silva Goncalves Bos, D., Szulcek, R., Schalij, I., … Bogaard, H. J. (2019). 6-mercaptopurine, an agonist of Nur77, reduces progression of pulmonary hypertension by enhancing BMP signalling. European Respiratory Journal, 1802400. Retrieved from https://browzine.com/articles/328731802

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free